PH27225A - Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols - Google Patents

Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols

Info

Publication number
PH27225A
PH27225A PH37315A PH37315A PH27225A PH 27225 A PH27225 A PH 27225A PH 37315 A PH37315 A PH 37315A PH 37315 A PH37315 A PH 37315A PH 27225 A PH27225 A PH 27225A
Authority
PH
Philippines
Prior art keywords
conjugates
coupled
molecular weight
high molecular
superoxide dismutase
Prior art date
Application number
PH37315A
Other languages
English (en)
Inventor
Mark Saifer
Ralph Somack
L David Williams
Original Assignee
Ddi Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ddi Pharmaceuticals filed Critical Ddi Pharmaceuticals
Publication of PH27225A publication Critical patent/PH27225A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/446Superoxide dismutase (1.15)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0089Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
PH37315A 1987-08-03 1988-07-29 Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols PH27225A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8100987A 1987-08-03 1987-08-03

Publications (1)

Publication Number Publication Date
PH27225A true PH27225A (en) 1993-05-04

Family

ID=22161332

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37315A PH27225A (en) 1987-08-03 1988-07-29 Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols

Country Status (17)

Country Link
EP (1) EP0377613B1 (da)
JP (1) JP2515389B2 (da)
KR (1) KR920001426B1 (da)
CN (1) CN1020458C (da)
AU (1) AU608901B2 (da)
CA (1) CA1309046C (da)
DE (1) DE3876997T2 (da)
DK (1) DK160842C (da)
ES (1) ES2007536A6 (da)
HU (1) HU203783B (da)
IE (1) IE64284B1 (da)
IL (1) IL87177A (da)
NZ (1) NZ225481A (da)
PH (1) PH27225A (da)
RU (1) RU1776275C (da)
WO (1) WO1989001033A1 (da)
ZA (1) ZA885249B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69033192T3 (de) 1989-04-19 2004-05-19 Enzon, Inc. Aktive karbonate von polyalkylenoxyden zur modifizierung von polypeptiden
US5109118A (en) * 1989-07-06 1992-04-28 Yutaka Mizushima Modified biologically active proteins
GB8919661D0 (en) * 1989-08-31 1989-10-11 Univ Alberta Superoxide dismutase-catalase conjugates
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
CA2114240A1 (en) * 1991-08-05 1993-02-18 Sterling Drug Inc. Buffered formulation of peg-sod
FR2687681B1 (fr) * 1992-02-20 1995-10-13 Transgene Sa Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses.
US5349001A (en) * 1993-01-19 1994-09-20 Enzon, Inc. Cyclic imide thione activated polyalkylene oxides
US5516703A (en) * 1993-08-20 1996-05-14 The University Of Utah Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands
US6284503B1 (en) 1993-08-20 2001-09-04 University Of Utah Research Foundation Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
US6638526B1 (en) 1998-06-23 2003-10-28 Novozymes A/S Polypeptides conjugated to copolymers of ethylene oxide and propylene oxide to reduce allergenicity
CA2332334A1 (en) * 1998-06-23 1999-12-29 Novozymes A/S A polypeptide-polymer conjugate
MXPA01000556A (es) * 1998-07-17 2002-05-14 Novozymes As Un conjugado de polipeptido-polimero con desempeno de lavado mejorado.
US20040062748A1 (en) 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US8129330B2 (en) 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
KR101238517B1 (ko) 2002-12-26 2013-02-28 마운틴 뷰 파마슈티컬즈, 인크. 생물학적 효능이 향상된 인터페론-베타의 중합체 접합체
NZ544024A (en) * 2003-05-12 2009-06-26 Affymax Inc Novel poly(ethylene glycol) modified compounds and uses thereof
CN108445106A (zh) * 2018-04-11 2018-08-24 南京明捷生物医药检测有限公司 一种药物中消泡剂聚丙二醇残留的检测方法
CN108864309B (zh) * 2018-07-26 2021-07-13 广州暨南大学医药生物技术研究开发中心有限公司 重组人sod-生长因子融合蛋白、其制备方法及其应用
CN109112119B (zh) * 2018-08-28 2022-04-26 佛山科学技术学院 经化学修饰的鸭血sod制剂的制备方法
CN117551625B (zh) * 2024-01-12 2024-03-08 山东爱维德生物科技有限公司 一种用于木立芦荟sod胶的聚乙二醇二胺-海藻酸改性sod酶及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74177A (en) * 1984-02-03 1989-09-10 Abbott Lab Stabilized enzyme conjugate composition containing a calcium salt and a polyethylene glycol
GB8430253D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
GB8430252D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
JPH084504B2 (ja) * 1985-04-26 1996-01-24 味の素株式会社 安定化ス−パ−オキサイドジスムタ−ゼ

Also Published As

Publication number Publication date
DE3876997D1 (de) 1993-02-04
CN1020458C (zh) 1993-05-05
EP0377613A1 (en) 1990-07-18
HUT52816A (en) 1990-08-28
JP2515389B2 (ja) 1996-07-10
NZ225481A (en) 1990-11-27
AU2326888A (en) 1989-03-01
CA1309046C (en) 1992-10-20
DE3876997T2 (de) 1993-04-29
IE64284B1 (en) 1995-07-26
WO1989001033A1 (en) 1989-02-09
IL87177A0 (en) 1988-12-30
DK160842C (da) 1991-10-14
ZA885249B (en) 1989-04-26
KR920001426B1 (ko) 1992-02-13
KR890701736A (ko) 1989-12-21
HU203783B (en) 1991-09-30
RU1776275C (ru) 1992-11-15
DK392789D0 (da) 1989-08-10
IE882206L (en) 1989-02-03
JPH02504341A (ja) 1990-12-13
ES2007536A6 (es) 1989-06-16
DK160842B (da) 1991-04-22
EP0377613B1 (en) 1992-12-23
IL87177A (en) 1992-08-18
CN1031088A (zh) 1989-02-15
AU608901B2 (en) 1991-04-18
DK392789A (da) 1989-08-10

Similar Documents

Publication Publication Date Title
ZA885249B (en) Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
NZ224275A (en) Low molecular weight heparin derivatives; pharmaceutical compositions
BG47944A3 (en) Design of road track for mobile toys
HK1014674A1 (en) Cell binding agent conjugates of derivatives of cc-1065
EP0200467A3 (en) Superoxide dismutase combined with a poly(alkylene oxide)
EP0296445A3 (en) Improvements to air springs
HK115594A (en) High molecular weight polystyrene blends with PPE and hips
GB8712520D0 (en) Conveying supporting & shaping glass sheets
IL79929A0 (en) Expression of superoxide dismutase
IT8948157A0 (it) Composizione di superossido dismutasi
IL87880A (en) Covalent oligonucleotide- horseradish peroxidase conjugates and their preparation
GB8919661D0 (en) Superoxide dismutase-catalase conjugates
GB8601128D0 (en) Imparting movement to baby cradle
EP0292321A3 (en) Acylated derivative of superoxide dismutase and composition containing same
GB2055373B (en) Preparation of vicinal alkylene glycols
GB2207352B (en) Use of papaverine in formulating anti-viral compositions
GB8613315D0 (en) Preparing conjugates of metalloproteins
IL71689A0 (en) Human superoxide dismutase production
ZA881743B (en) Human manganese superoxide dismutase(hmn-sod)
IE862324L (en) Cloned superoxide dismutase
PL263081A1 (en) Mobile trackway to autoclave
GB8806664D0 (en) Improvements in/relating to trolleys for supporting missiles
IE873096L (en) Preparation of low molecular weight glucosaminoglycans
GB9026229D0 (en) Tolerogenic conjugates for suppressing immune responses
GR871647B (en) Personal flat pocket glass